Ironwood Pharmaceuticals (NASDAQ:IRWD) Lowered to “Hold” Rating by StockNews.com
StockNews.com lowered shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) from a buy rating to a hold rating in a report issued on Friday morning. IRWD has been the topic of several other reports. JMP Securities reduced their target price on Ironwood Pharmaceuticals from $23.00 to $14.00 and set a “market outperform” rating on the […]
